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In This IssueStem cells have two remarkable abilities: they can self-renew to keep the stem cell pool replenished, and
they can differentiate into a wide variety of cell types. This stunning biological duality intrigues not only
those interested in the basic mechanisms of development, differentiation, and reprogramming, but
also those who seek to use stem cells therapeutically to replace lost or damaged tissue. But when did
the stem cell revolution start? It was back in the 1960s that two Canadian researchers, Ernest A. McCul-
loch and James E. Till, launched the field of stem cell research with their groundbreaking work on the he-
matopoietic stem cells of mouse bonemarrow. By designing clonogenic assays tomeasure stem cell dif-
ferentiation in vitro and serial transplantation assays to study stem cell repopulating ability in vivo, Till and
McCulloch defined the hallmark characteristics of stem cells.
The field of stem cell research has come a long way in 50 years, as we hope will be apparent from this
year’s Special Review Issue. Our goal in this issue is to highlight the remarkable biological features of
stem cells, the molecular pathways that control these characteristics, and the ways in which these enig-
matic cells can be exploited for cell replacement therapy. We would like to thank the many distinguished
experts who contributed their time and efforts as authors and reviewers to make this special issue on
stem cells informative, thought-provoking, and timely. We hope that this collection of articles conveys
the excitement and promise of stem cell research, as we enter a new era of possibility.
Stem Cells 101
Understanding what makes stem cells self-renew and what drives them to differentiate is crucial if these cells are going to be of value
therapeutically. Using the fruit fly Drosophila as a model, Juergen Knoblich (Page 583) reviews a key mechanism that dictates stem
cell self-renewal and differentiation: asymmetric cell division. As Knoblich explains, asymmetric cell division may regulate stem cells
in two ways: by distributing self-renewal factors to only one daughter cell, or by ensuring that only one daughter maintains contact
with the niche and so retains a stem cell fate.
The niche is the unique environment in which stem cells reside, and the signals it produces are essential for regulating stem cell
maintenance, as we learn from Sean Morrison and Allan Spradling (see Review, Page 598). As these authors discuss, the signals in
the Drosophila gonad that maintain its resident population of germline stem cells have been elucidated, and many of the same prin-
ciples may also apply to the stem cell niches of more complex organisms. In their Minireview (Page 559), Ryan Cinalli, Prashanth
Rangan, and Ruth Lehmann discuss the uniqueness of germline stem cells, which are both totipotent, a characteristic that reappears
at fertilization, and unipotent, capable of producing only eggs or sperm. These authors propose that germline stem cells must fight to
suppress differentiation programs in order to maintain their dualistic nature. The niche is also important for the maintenance of plant
stem cells and for directing their differentiation to become roots, shoots, or leaves, as Jose Dinneny and Philip Benfey discuss in their
Essay (Page 553).
Once stem cells leave their niche, where do they go, and how do they get there? Certain stem cells such as hematopoietic stem
cells of adult bone marrow and the primordial germ cells of the embryo have remarkable homing capabilities, migrating over long
distances to their final destinations, as Diane Laird, Uli von Andrian, and AmyWagers detail in their Review (Page 612). Understanding
themolecular signals that direct stem cell homingwill be important for developing protocols to ensure that stem cell populations used
therapeutically will migrate to sites of tissue injury after transplantation.
As Kenneth Birnbaum and Alejandro Sa´nchez Alvarado remind us, there is much we can learn about tissue repair and regenera-
tion from simpler organisms with a remarkable regenerative capacity, such as planarians, amphibians, and plants (see Review,
Page 697).
Directing Stem Cell Differentiation
Elucidating the molecular programs that direct embryonic stem (ES) cells along
the road to differentiation is important not only for understanding basic mecha-
nisms in development but also for pinpointing how to obtain the cell type of in-
terest for replacement therapy, as we learn from Chuck Murry and Gordon Keller
(see Review, Page 661). These authors discuss commonalities in the signaling
pathways governing establishment of the three germ layers during early embry-
onic development and the earliest stages of ES cell differentiation. They then
describe the molecular signals that drive ES cells to differentiate into several
cell types of particular therapeutic interest including cardiomyocytes for treating
heart disease, dopaminergic neurons for replacing the nigrostriatal neurons that
die in Parkinson’s disease, and insulin-producing pancreatic islet b cells to
replace those lost in type I diabetes.
Although the biology of ES cells and the cells they are able to become will con-
tinue to be a key research area, it will be important to elucidate the biology of
endogenous stem cell populations in the adult and their ability to repair damaged
tissue in situ. In their Essay (Page 537), Sean Wu, Ken Chien, and Christine
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Mummery compare the characteristics of fetal and adult cardiac progenitor cells and the differing capacities of these cells for repair-
ing damaged heart tissue. And Chunmei Zhao, Wei Deng, and Fred Gage (Page 645) review the factors that regulate proliferation and
fate determination of neural stem cells in the adult mammalian brain, explaining how defective neurogenesis may be involved in neu-
rological disorders such as depression and Alzheimer’s disease. The theme of differences between fetal and adult stem cell biology is
taken further along the spectrum of life by Derrick Rossi, Catriona Jamieson, and Irving Weissman, who explore alterations to stem
cells as adults age (see Review, Page 681). In particular, an upset in the delicate balance between stem cell self-renewal and differ-
entiation may contribute to a number of aging-related diseases, including cancer.
Deconstructing the best-studied stem cell system in mammals, Stuart Orkin and Len Zon dissect the complex transcriptional net-
works that govern each stage of hematopoietic stem cell differentiation (see Review, Page 631 and SnapShot, Page 712). They also
point out the emerging role of microRNAs, which provide an additional level of stem cell regulation, a theme that is developed further
by Bradford Stadler and Hannele Ruohola-Baker in their Minireview (Page 563).
Leaping the Reprogramming Hurdle
A better understanding of the transcriptional networks that modulate stem cell differentiation and the maintenance of pluripotency
has set the stage for a recent dramatic leap forward in stem cell research, the reprogramming of adult human somatic cells back
to an embryonic stem cell-like fate. Rudolf Jaenisch and Richard Young (see Review, Page 567) describe how a simple cocktail con-
taining as few as three master transcription factors can coax adult human somatic cells to assume an embryonic-like fate. The re-
sulting induced pluripotent stem (iPS) cells hold great promise for understanding disease mechanisms, because they bring much
closer the reality of generating disease-specific embryonic stem cell lines directly from patients.
Although the ability to induce pluripotency through reprogramming is a huge breakthrough, most stem cell researchers agree that
human embryonic stem cells will remain the gold standard and that research on these cells cannot be abandoned. In her Essay (Page
527), Janet Rossant compares the equivalence of embryonic stem cells, iPS cells, and the many other varieties of stem cells derived
from the embryo. And in a related Essay (Page 532), Jose Silva and Austin Smith argue that variations within stem cell populations
ensure that only a subpopulation of stem cells ‘‘capture and retain’’ pluripotency.
The Challenges of Cell Replacement Therapy
Drawing on the theme of regulating pluripotency, George Daley and David Scadden (see Essay, Page 544) describe various strate-
gies for the therapeutic application of stem cells and the various biological challenges, such as immune rejection, that must be over-
come before stem cells enter the clinic. Meanwhile, Lee Rubin reminds us (see Essay, Page 549) that an important application of
embryonic stem cells and iPS cells—and one that is likely to arrive before cell replacement therapy—is in the arena of drug screening
and toxicity testing. Providing a perspective on the step between the laboratory and the clinic, Ann Parson (see Analysis, Page 511)
reports on the challenges faced by regenerative medicine biotech companies in attracting interest from venture capital funders and
big pharma. This article also touches on some of the engineering challenges for translational research including purity of the stem cell
populations, scalability (how to get sufficient numbers of the correct cell), and meeting Good Manufacturing Practice requirements.
The Future
As stem cell research surges ahead, individual states and even city-states, are leading the charge to make stem cell research and
regenerative medicine a pivotal element of their R&D portfolios. Looking West, two Commentaries present the views of Alan Troun-
son, the new director of the California Institute for Regenerative Medicine (Page 522), and Alan Colman, executive director of
Singapore’s StemCell Consortium. Although stem cells hold remarkable potential both for understanding themolecular mechanisms
governing normal development as well as future therapeutic applications, there is still much debate about whether valuable human
embryonic stem cell lines should be patented, as Laura Bonetta reports in her Analysis (Page 514).
And if this special issue has piqued your interest in the latest stem cell research, why not return to the beginning to sample our
Select pages (Page 505). Here, Heather Fleming, reviews editor of Cell Stem Cell, highlights exciting recent papers about the
stem cell niche, skeletal muscle regeneration, and the role of cancer stem cells in melanoma and liver cancer. We hope you are
left in no doubt that, for stem cell research, the future is now.
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